Skip to content

Treatment of Molluscum contagiosum in paediatric age group with Individualized Homoeopathic medicine and Kalium bromatum

Assessing the effectiveness of kalium bromatum and individualized homeopathic medicine in the management of molluscum contagiosum in paediatric subjects a comparitive study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102448
Enrollment
60
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Kalium bromatum and Individualized Homoeopathic medicine: Among 2 groups Kalium bromatum will be given to subjects having Kalium bromatum symptoms and remaining subjects will be given i
sometimes pustules in centre of patches that become umbilicated 2 Exuding a creamy moisture and forming thick yellow scabs 3 Eruption of small boils in successive crops, mostly on face and trunk with

Sponsors

Dr Varshitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subject parents or legal guardian who are willing to sign the written consent for their child to participate voluntarily and assent of the child more than 7 years of age. 2 Subjects aged between 1-18 years of age group. 3 Subject newly diagnosed cases of Molluscum seeking Homoeopathic treatment.

Exclusion criteria

Exclusion criteria: 1 Subjects with complication such as secondary Bacterial infection, Molluscum Dermatitis, Molluscum Balanitis or Vulvitis, Conjunctivitis. 2 Subjects suffering from other illness like Atopic Dermatitis, Verruca vulgaris, Milia, Impetigo, Lichen planus. 3 Subjects receiving treatment for other medical illness.

Design outcomes

Primary

MeasureTime frame
Disappearance of symptoms of Molluscum contagiosum by the end of 12 weeksTimepoint: By the end of 12 weeks

Secondary

MeasureTime frame
Reduction of symptoms of molluscum contagiosum by the end of 24 weeksTimepoint: By the end of 24 weeks

Countries

India

Contacts

Public ContactDr Varshitha P

Government Homoeopathic Medical College and Hospital

sheelaravi24jr@gmail.com7795355548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026